Select your region

Product availability, approved indications and certain content on this website vary by country.

Investor relations

SS Innovations International, Inc. is listed on the Nasdaq Capital Market under the symbol SSII.

Nasdaq: SSIIDelayed quote

Real-time and delayed quotes for SSII are available from Nasdaq.

SSII on Nasdaq

Business overview

SS Innovations develops differentiated surgical robotic technologies, led by the cost-efficient SSi Mantra surgical robotic system, which supports a wide range of procedures including cardiac surgery. The company's mission is to make the benefits of robotic surgery available to a far wider global population.

Investor presentation, October 2026

Investment highlights

Differentiated platformA clinically and commercially differentiated, cost-efficient surgical robotics platform.
Large addressable marketA large and growing market with favourable industry tailwinds.
Global expansionAn established presence in India, with expansion underway internationally.
Recurring revenueStrong sales growth with an increasing mix of recurring consumables revenue.
TelesurgeryThe first surgical robot approved by India's CDSCO for telesurgery and teleproctoring.
Experienced leadershipA leadership team with deep surgical and industry experience.

Financial results

$42.5MRevenue, full year 2025
46.0%Gross margin, 2025
$13.9MRevenue, Q2 2026
244Installed base, 28 Sep 2026

Source: company presentation, October 2026, and quarterly results. See SEC filings for complete financial statements.

SEC filings

All filings on EDGAR
DateFormDescription
13 Oct 20268-KCurrent report: other eventsView
13 Oct 20268-KCurrent report: material agreement, financial obligationView
9 Oct 2026424B5Prospectus supplementView
5 Oct 20268-KCurrent report: regulation fd disclosureView
10 Sep 20268-KCurrent report: other eventsView
26 Aug 20268-KCurrent report: officers and directorsView
13 Aug 20268-KCurrent report: financial results, regulation fd disclosureView
13 Aug 202610-QQuarterly reportView
17 Jul 20268-KCurrent report: other eventsView
14 Jul 20268-KCurrent report: officers and directorsView
7 Jul 20268-KCurrent report: other eventsView
30 Jun 20268-KCurrent report: other eventsView
18 Jun 20268-KCurrent report: material agreementView
18 Jun 2026424B5Prospectus supplementView
15 Jun 20268-KCurrent report: regulation fd disclosureView

Latest 15 filings from SEC EDGAR, updated 22 October 2026. Section 16 ownership reports are on EDGAR.

Events and presentations

Investor presentation

Download PDF

Stifel 2025 Healthcare Conference

Webcast replay

Upcoming investor events will be announced here and by press release.

Analyst coverage

  • Lucid Capital MarketsAlex Nowak, CFA

Opinions, estimates or forecasts made by analysts are theirs alone and do not represent those of SS Innovations or its management.

Corporate governance

Board of directors

Directors of SS Innovations International, Inc.

Governance documents

Insider trading policy and compliance program (PDF, August 2026)

Investor contact

investors@ssinnovations.org
1600 SE 15th Street, #512, Fort Lauderdale, Florida 33316

Investor relations: Kalle Ahl, CFA, The Equity Group
+1 303 953 9878 · kalle.ahl@theequitygroup.com

Forward-looking statements. Certain statements on this website constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Please refer to our notice on forward-looking statements and to the Company's filings with the U.S. Securities and Exchange Commission.